[Clinical study of bufexamac ointment in gynecology and obstetrics].
D000038:Abscess / Q000188:drug therapy; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001941:Breast Diseases / Q000188:drug therapy; D002921:Cicatrix / Q000188:drug therapy; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006484:Hemorrhoids / Q000188:drug therapy*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy; D008205:Lymphangitis / Q000188:drug therapy*; D009824:Ointments / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D010689:Phlebitis / Q000188:drug therapy*; D014847:Vulvitis / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D009824:Ointments; D010648:Phenylacetates
Etude clinique de bufexamac crème en gynécologie et en obstétrique.